Ładuje się......
Virtual screening of novel compounds as potential ER-alpha inhibitors
Majority of breast cancers diagnosed today are estrogen receptor (ER)-positive, however, progesterone receptor-positive (PR-positive) is also responsible for breast cancer. Tumors that are ER/PR-positive are much more likely to respond to hormone therapy than tumors that are ER/PR-negative. Nearly 1...
Zapisane w:
| Wydane w: | Bioinformation |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Biomedical Informatics
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6589477/ https://ncbi.nlm.nih.gov/pubmed/31249434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630015321 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|